Key Points Interested in iShares Biotechnology ETF? Here are five stocks we like better. The iShares Nasdaq Biotechnology ETF ...
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to ...
You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on February 5, ...
Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...
Today, Zacks Investment Ideas feature highlights iShares Biotechnology ETF IBB, Novartis NVS, Pfizer PFE and Eli Lilly’s LLY.
Broad healthcare diversification or concentrated biotech growth? Compare cost, risk, and portfolio composition to find your ...
I reiterate a Hold rating on the iShares Nasdaq Biotechnology ETF, citing modest valuation but lackluster momentum and unfavorable market themes. IBB lags the S&P 500 YTD and faces headwinds as ...
Following the sale, iShares Biotechnology ETF is comprised 2.67% of DAFNA Capital’s 13F reportable assets under management. Top five holdings after the filing: NASDAQ:RVMD: $48.15 million (11.3% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results